These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20311870)

  • 1. Double-blind studies.
    Reich CJ
    Can Med Assoc J; 1972 Feb; 106(4):307. PubMed ID: 20311870
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanel.
    Montouris G; Yang H; Williams B; Zhou S; Laurenza A; Fain R
    Epilepsy Res; 2015 Aug; 114():131-40. PubMed ID: 26088896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the efficacy of atypical antipsychotics in open uncontrolled versus double-blind controlled trials in schizophrenia.
    Pajonk FG; Holzbach R; Naber D
    Psychopharmacology (Berl); 2002 Jun; 162(1):29-36. PubMed ID: 12107614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Centered Outcomes with Aripiprazole Once-Monthly for Maintenance Treatment in Patients with Schizophrenia: Results From Two Multicenter, Randomized, Double-Blind Studies.
    Kane JM; Sanchez R; Baker RA; Eramo A; Peters-Strickland T; Perry PP; Johnson BR; Tsai LF; Carson WH; McQuade RD; Fleischhacker WW
    Clin Schizophr Relat Psychoses; 2015; 9(2):79-87. PubMed ID: 25711509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do open label blinded outcome studies of novel anticoagulants versus warfarin have equivalent validity to those carried out under double-blind conditions?
    O'Neil WM; Welner SA; Lip GY
    Thromb Haemost; 2013 Mar; 109(3):497-503. PubMed ID: 23348922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The double-blind variable placebo lead-in period: results from two antidepressant clinical trials.
    Faries DE; Heiligenstein JH; Tollefson GD; Potter WZ
    J Clin Psychopharmacol; 2001 Dec; 21(6):561-8. PubMed ID: 11763002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Open studies in comparison to controlled studies in testing of neuroleptics].
    Pajonk FG; Holzbach R; Naber D
    Fortschr Neurol Psychiatr; 2000 Jul; 68(7):313-20. PubMed ID: 10945157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial.
    Zakrzewska JM; Palmer J; Morisset V; Giblin GM; Obermann M; Ettlin DA; Cruccu G; Bendtsen L; Estacion M; Derjean D; Waxman SG; Layton G; Gunn K; Tate S;
    Lancet Neurol; 2017 Apr; 16(4):291-300. PubMed ID: 28216232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter, double-blind study of intravenous milrinone for patients with acute heart failure in Japan. Japan Intravenous Milrinone Investigators.
    Seino Y; Momomura S; Takano T; Hayakawa H; Katoh K
    Crit Care Med; 1996 Sep; 24(9):1490-7. PubMed ID: 8797620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How "blind" are double-blind studies?
    Margraf J; Ehlers A; Roth WT; Clark DB; Sheikh J; Agras WS; Taylor CB
    J Consult Clin Psychol; 1991 Feb; 59(1):184-7. PubMed ID: 2002136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
    Lipton RB; Munjal S; Brand-Schieber E; Rapoport AM
    Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Safety and Efficacy of Fulranumab in Patients With Moderate-to-Severe Osteoarthritis Pain: A Phase II Randomized, Double-Blind, Placebo-Controlled Extension Study.
    Sanga P; Katz N; Polverejan E; Wang S; Kelly KM; Haeussler J; Thipphawong J
    Arthritis Rheumatol; 2017 Apr; 69(4):763-773. PubMed ID: 27748055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose conversion between tapentadol immediate and extended release for low back pain.
    Etropolski MS; Okamoto A; Shapiro DY; Rauschkolb C
    Pain Physician; 2010; 13(1):61-70. PubMed ID: 20119464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
    Sorge J; Sittl R
    Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled trials of inositol in psychiatry.
    Levine J
    Eur Neuropsychopharmacol; 1997 May; 7(2):147-55. PubMed ID: 9169302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study.
    Llorca PM; Spadone C; Sol O; Danniau A; Bougerol T; Corruble E; Faruch M; Macher JP; Sermet E; Servant D
    J Clin Psychiatry; 2002 Nov; 63(11):1020-7. PubMed ID: 12444816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endurance testing for evaluation of antianginal therapy with amlodipine, a calcium channel blocking agent.
    Kinnard DR; Harris M; Hossack KF
    J Am Coll Cardiol; 1988 Sep; 12(3):791-6. PubMed ID: 2969930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension.
    Gault LM; Lenz RA; Ritchie CW; Meier A; Othman AA; Tang Q; Berry S; Pritchett Y; Robieson WZ
    Alzheimers Res Ther; 2016 Oct; 8(1):44. PubMed ID: 27756421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind versus deceptive administration of a placebo.
    Kirsch I; Weixel LJ
    Behav Neurosci; 1988 Apr; 102(2):319-23. PubMed ID: 3365327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cases for and against double-blind reviews.
    Cox AR; Montgomerie R
    PeerJ; 2019; 7():e6702. PubMed ID: 30972261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.